Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 310

1.

Targeting the Cell Stress Response of Plasmodium falciparum to Overcome Artemisinin Resistance.

Dogovski C, Xie SC, Burgio G, Bridgford J, Mok S, McCaw JM, Chotivanich K, Kenny S, Gnädig N, Straimer J, Bozdech Z, Fidock DA, Simpson JA, Dondorp AM, Foote S, Klonis N, Tilley L.

PLoS Biol. 2015 Apr 22;13(4):e1002132. doi: 10.1371/journal.pbio.1002132. eCollection 2015 Apr.

2.

Plasmodium knowlesi gene expression differs in ex vivo compared to in vitro blood-stage cultures.

Lapp SA, Mok S, Zhu L, Wu H, Preiser PR, Bozdech Z, Galinski MR.

Malar J. 2015 Mar 13;14(1):110. doi: 10.1186/s12936-015-0612-8.

3.

Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAFV600E melanoma.

Hu-Lieskovan S, Mok S, Homet Moreno B, Tsoi J, Robert L, Goedert L, Pinheiro EM, Koya RC, Graeber TG, Comin-Anduix B, Ribas A.

Sci Transl Med. 2015 Mar 18;7(279):279ra41. doi: 10.1126/scitranslmed.aaa4691.

PMID:
25787767
4.

Drug resistance. Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance.

Mok S, Ashley EA, Ferreira PE, Zhu L, Lin Z, Yeo T, Chotivanich K, Imwong M, Pukrittayakamee S, Dhorda M, Nguon C, Lim P, Amaratunga C, Suon S, Hien TT, Htut Y, Faiz MA, Onyamboko MA, Mayxay M, Newton PN, Tripura R, Woodrow CJ, Miotto O, Kwiatkowski DP, Nosten F, Day NP, Preiser PR, White NJ, Dondorp AM, Fairhurst RM, Bozdech Z.

Science. 2015 Jan 23;347(6220):431-5. doi: 10.1126/science.1260403. Epub 2014 Dec 11.

PMID:
25502316
5.

CAF reprogramming inhibits ovarian cancer progression.

Yeung TL, Leung CS, Mok SC.

Cell Cycle. 2014;13(24):3783-4. doi: 10.4161/15384101.2014.988106. No abstract available.

PMID:
25483059
6.

Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential.

Leung CS, Yeung TL, Yip KP, Pradeep S, Balasubramanian L, Liu J, Wong KK, Mangala LS, Armaiz-Pena GN, Lopez-Berestein G, Sood AK, Birrer MJ, Mok SC.

Nat Commun. 2014 Oct 3;5:5092. doi: 10.1038/ncomms6092.

7.

Recurrent nocturnal hypoglycemia in a patient with type 1 diabetes mellitus.

Loh TP, Mok SF, Kao SL, Khoo E, Thai AC.

Clin Chem. 2014 Oct;60(10):1267-70. doi: 10.1373/clinchem.2013.214676. No abstract available.

PMID:
25267512
8.

Distinct immunological mechanisms of CTLA-4 and PD-1 blockade revealed by analyzing TCR usage in blood lymphocytes.

Robert L, Harview C, Emerson R, Wang X, Mok S, Homet B, Comin-Anduix B, Koya RC, Robins H, Tumeh PC, Ribas A.

Oncoimmunology. 2014 Jun 25;3:e29244. eCollection 2014.

9.

Loss of LKB1 in high-grade endometrial carcinoma: LKB1 is a novel transcriptional target of p53.

Co NN, Iglesias D, Celestino J, Kwan SY, Mok SC, Schmandt R, Lu KH.

Cancer. 2014 Nov 15;120(22):3457-68. doi: 10.1002/cncr.28854. Epub 2014 Jul 16.

PMID:
25042259
10.
11.

Diagnosing dengue at the point-of-care: utility of a rapid combined diagnostic kit in Singapore.

Gan VC, Tan LK, Lye DC, Pok KY, Mok SQ, Chua RC, Leo YS, Ng LC.

PLoS One. 2014 Mar 19;9(3):e90037. doi: 10.1371/journal.pone.0090037. eCollection 2014.

12.

High-throughput screen of natural product extracts in a yeast model of polyglutamine proteotoxicity.

Walter GM, Raveh A, Mok SA, McQuade TJ, Arevang CJ, Schultz PJ, Smith MC, Asare S, Cruz PG, Wisen S, Matainaho T, Sherman DH, Gestwicki JE.

Chem Biol Drug Des. 2014 Apr;83(4):440-9. doi: 10.1111/cbdd.12259.

13.

Flavonoids from Herba epimedii selectively activate estrogen receptor alpha (ERα) and stimulate ER-dependent osteoblastic functions in UMR-106 cells.

Xiao HH, Fung CY, Mok SK, Wong KC, Ho MX, Wang XL, Yao XS, Wong MS.

J Steroid Biochem Mol Biol. 2014 Sep;143:141-51. doi: 10.1016/j.jsbmb.2014.02.019. Epub 2014 Mar 6.

PMID:
24607839
14.

CTLA4 blockade broadens the peripheral T-cell receptor repertoire.

Robert L, Tsoi J, Wang X, Emerson R, Homet B, Chodon T, Mok S, Huang RR, Cochran AJ, Comin-Anduix B, Koya RC, Graeber TG, Robins H, Ribas A.

Clin Cancer Res. 2014 May 1;20(9):2424-32. doi: 10.1158/1078-0432.CCR-13-2648. Epub 2014 Feb 28.

15.

KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma.

Tsang YT, Deavers MT, Sun CC, Kwan SY, Kuo E, Malpica A, Mok SC, Gershenson DM, Wong KK.

J Pathol. 2013 Dec;231(4):449-56. doi: 10.1002/path.4252.

16.

Assessment of iron overload in very young children with limited thalassemia care resources in South China.

Au WY, Li CF, Fang JP, Chen GF, Sun X, Li CG, Zhang XH, Wu XD, Gao HY, Hao WG, Rasalkar D, Deng M, Mok SP, Tricta F, Chu WC.

Hemoglobin. 2014;38(2):119-26. doi: 10.3109/03630269.2014.880715. Epub 2014 Feb 7.

PMID:
24502375
17.

ECplot: an online tool for making standardized plots from large datasets for bioinformatics publications.

Fok AC, Mok SS, Lee SD, Yip KY.

Bioinformatics. 2014 May 15;30(10):1467-8. doi: 10.1093/bioinformatics/btu038. Epub 2014 Jan 24.

PMID:
24463182
18.

Structural polymorphism in the promoter of pfmrp2 confers Plasmodium falciparum tolerance to quinoline drugs.

Mok S, Liong KY, Lim EH, Huang X, Zhu L, Preiser PR, Bozdech Z.

Mol Microbiol. 2014 Mar;91(5):918-34. doi: 10.1111/mmi.12505. Epub 2014 Jan 23.

19.

Vanishing bile duct syndrome as a manifestation of Hodgkin's lymphoma: a case report and review of the literature.

Nader K, Mok S, Kalra A, Harb A, Schwarting R, Ferber A.

Tumori. 2013 Jul-Aug;99(4):e164-8. doi: 10.1700/1361.15117. Review.

PMID:
24326854
20.

Human omental-derived adipose stem cells increase ovarian cancer proliferation, migration, and chemoresistance.

Nowicka A, Marini FC, Solley TN, Elizondo PB, Zhang Y, Sharp HJ, Broaddus R, Kolonin M, Mok SC, Thompson MS, Woodward WA, Lu K, Salimian B, Nagrath D, Klopp AH.

PLoS One. 2013 Dec 2;8(12):e81859. doi: 10.1371/journal.pone.0081859. eCollection 2013.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk